Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Man Zhao

Showing results (431-440 of 448) with videos related to

Pageof 45
Sort By:
Nature Communications|February 5, 2026
Paper-based fluorescent assay for blood typing and antibody titer determination using long-term ambient-stored bioengineered RBCsYuxuan Li, Yulong Zhang, Shengqiang Liang, et al.
The Science of the Total Environment|July 6, 2023
Contribution of the bacterial community of poorly fermented oat silage to biogas emissions on the Qinghai Tibetan PlateauChaosheng Liao, Binbin Na, Xiaolong Tang, et al.
Huan Jing Ke Xue= Huanjing Kexue|July 3, 2018
[Particle Size Distribution and Human Health Risk Assessment of Heavy Metals in Atmospheric Particles from Beijing and Xinxiang During Summer]Xin Zhang, Xiao-Man Zhao, Xue-Jie Meng, et al.
Annals of Hematology|September 23, 2024
Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS studyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Nutrition & Metabolism|January 3, 2024
Deficiency of Trex1 leads to spontaneous development of type 1 diabetesJiang-Man Zhao, Zhi-Hui Su, Qiu-Ying Han, et al.
Annals of Hematology|September 3, 2024
Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS StudyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Annals of Hematology|May 23, 2025
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS studyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Cancer Research|February 6, 2023
HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer ProgressionYufei Wang, Man Zhao, Lina Zhao, et al.
Journal of Medicinal Chemistry|February 2, 2026
Arylidene-Thiazoldione Scaffold Acts as the E3 Ligand of DCAF11 for PROTAC DesignJinyi Liang, Yuyang Liu, Man Zhao, et al.
Journal of Hepatology|October 18, 2025
HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responsesHongfeng Yuan, Lina Zhao, Guang Yang, et al.
Pageof 45

Showing results (431-440 of 448) with videos related to

Sort By:
Pageof 45
Nature Communications|February 5, 2026
Paper-based fluorescent assay for blood typing and antibody titer determination using long-term ambient-stored bioengineered RBCsYuxuan Li, Yulong Zhang, Shengqiang Liang, et al.
The Science of the Total Environment|July 6, 2023
Contribution of the bacterial community of poorly fermented oat silage to biogas emissions on the Qinghai Tibetan PlateauChaosheng Liao, Binbin Na, Xiaolong Tang, et al.
Huan Jing Ke Xue= Huanjing Kexue|July 3, 2018
[Particle Size Distribution and Human Health Risk Assessment of Heavy Metals in Atmospheric Particles from Beijing and Xinxiang During Summer]Xin Zhang, Xiao-Man Zhao, Xue-Jie Meng, et al.
Annals of Hematology|September 23, 2024
Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS studyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Nutrition & Metabolism|January 3, 2024
Deficiency of Trex1 leads to spontaneous development of type 1 diabetesJiang-Man Zhao, Zhi-Hui Su, Qiu-Ying Han, et al.
Annals of Hematology|September 3, 2024
Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS StudyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Annals of Hematology|May 23, 2025
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS studyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Cancer Research|February 6, 2023
HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer ProgressionYufei Wang, Man Zhao, Lina Zhao, et al.
Journal of Medicinal Chemistry|February 2, 2026
Arylidene-Thiazoldione Scaffold Acts as the E3 Ligand of DCAF11 for PROTAC DesignJinyi Liang, Yuyang Liu, Man Zhao, et al.
Journal of Hepatology|October 18, 2025
HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responsesHongfeng Yuan, Lina Zhao, Guang Yang, et al.
Pageof 45